The Valley Desk

NCT02535078 · Interventional trial

Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma

Overall registry status Withdrawn

Phase 1 · Phase 2

Conditions Malignant Melanoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov